Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAIC with or without Zoledronic Acid in Advanced HCC
NCT05866172Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- May 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zoledronic acid in hepatocellular carcinoma (HCC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
zoledronic acid
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT05866172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05866172.